Glixis Therapeutics Overview

  • Founded
  • 2012


  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Glixis Therapeutics General Information


Developer of novel therapies designed for autoimmune diseases. The company has engineered a pro-drug with a proprietary chemical structure that targets an underlying mechanism of progressive multiple sclerosis with secondary benefits to relapse and remit itself, enabling physicians to formulate a drug that can efficiently work for the smooth functioning between the brain and the body.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Primary Office
  • 122 Calistoga Road
  • Suite 346
  • Santa Rosa, CA 95409
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glixis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 14-Jan-2021 Completed Out of Business
2. Grant 12-Jun-2014 00000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Glixis Therapeutics’s complete valuation and funding history, request access »